119 related articles for article (PubMed ID: 19489071)
1. Strain-dependent viral dynamics and virus-cell interactions in a novel in vitro system supporting the life cycle of blood-borne hepatitis C virus.
Aly HH; Qi Y; Atsuzawa K; Usuda N; Takada Y; Mizokami M; Shimotohno K; Hijikata M
Hepatology; 2009 Sep; 50(3):689-96. PubMed ID: 19489071
[TBL] [Abstract][Full Text] [Related]
2. Thromboxane A2 synthase inhibitors prevent production of infectious hepatitis C virus in mice with humanized livers.
Abe Y; Aly HH; Hiraga N; Imamura M; Wakita T; Shimotohno K; Chayama K; Hijikata M
Gastroenterology; 2013 Sep; 145(3):658-67.e11. PubMed ID: 23684750
[TBL] [Abstract][Full Text] [Related]
3. Serum-derived hepatitis C virus infectivity in interferon regulatory factor-7-suppressed human primary hepatocytes.
Aly HH; Watashi K; Hijikata M; Kaneko H; Takada Y; Egawa H; Uemoto S; Shimotohno K
J Hepatol; 2007 Jan; 46(1):26-36. PubMed ID: 17112629
[TBL] [Abstract][Full Text] [Related]
4. Long-term propagation of serum hepatitis C virus (HCV) with production of enveloped HCV particles in human HepaRG hepatocytes.
Ndongo-Thiam N; Berthillon P; Errazuriz E; Bordes I; De Sequeira S; Trépo C; Petit MA
Hepatology; 2011 Aug; 54(2):406-17. PubMed ID: 21520209
[TBL] [Abstract][Full Text] [Related]
5. Replication and infectivity of a novel genotype 1b hepatitis C virus clone.
Date T; Morikawa K; Tanaka Y; Tanaka-Kaneko K; Sata T; Mizokami M; Wakita T
Microbiol Immunol; 2012 May; 56(5):308-17. PubMed ID: 22320232
[TBL] [Abstract][Full Text] [Related]
6. Primary hepatocyte culture supports hepatitis C virus replication: a model for infection-associated hepatocarcinogenesis.
Banaudha K; Orenstein JM; Korolnek T; St Laurent GC; Wakita T; Kumar A
Hepatology; 2010 Jun; 51(6):1922-32. PubMed ID: 20512986
[TBL] [Abstract][Full Text] [Related]
7. Matrigel-embedded 3D culture of Huh-7 cells as a hepatocyte-like polarized system to study hepatitis C virus cycle.
Molina-Jimenez F; Benedicto I; Dao Thi VL; Gondar V; Lavillette D; Marin JJ; Briz O; Moreno-Otero R; Aldabe R; Baumert TF; Cosset FL; Lopez-Cabrera M; Majano PL
Virology; 2012 Mar; 425(1):31-9. PubMed ID: 22280897
[TBL] [Abstract][Full Text] [Related]
8. Production of infectious hepatitis C virus in primary cultures of human adult hepatocytes.
Podevin P; Carpentier A; Pène V; Aoudjehane L; Carrière M; Zaïdi S; Hernandez C; Calle V; Méritet JF; Scatton O; Dreux M; Cosset FL; Wakita T; Bartenschlager R; Demignot S; Conti F; Rosenberg AR; Calmus Y
Gastroenterology; 2010 Oct; 139(4):1355-64. PubMed ID: 20600021
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells.
Eyre NS; Phillips RJ; Bowden S; Yip E; Dewar B; Locarnini SA; Beard MR
J Hepatol; 2009 Sep; 51(3):446-57. PubMed ID: 19596477
[TBL] [Abstract][Full Text] [Related]
10. Acquisition of susceptibility to hepatitis C virus replication in HepG2 cells by fusion with primary human hepatocytes: establishment of a quantitative assay for hepatitis C virus infectivity in a cell culture system.
Ito T; Yasui K; Mukaigawa J; Katsume A; Kohara M; Mitamura K
Hepatology; 2001 Sep; 34(3):566-72. PubMed ID: 11526543
[TBL] [Abstract][Full Text] [Related]
11. Primary cultures of human hepatocytes isolated from hepatitis C virus-infected cirrhotic livers as a model to study hepatitis C infection.
Raymond VA; Selliah S; Ethier C; Houle R; Jouan L; Maniere T; Lamarre D; Willems B; Bilodeau M
Liver Int; 2009 Jul; 29(6):942-9. PubMed ID: 19302183
[TBL] [Abstract][Full Text] [Related]
12. In vitro models for analysis of the hepatitis C virus life cycle.
Aly HH; Shimotohno K; Hijikata M; Seya T
Microbiol Immunol; 2012 Jan; 56(1):1-9. PubMed ID: 22145950
[TBL] [Abstract][Full Text] [Related]
13. 3D cultured immortalized human hepatocytes useful to develop drugs for blood-borne HCV.
Aly HH; Shimotohno K; Hijikata M
Biochem Biophys Res Commun; 2009 Feb; 379(2):330-4. PubMed ID: 19103167
[TBL] [Abstract][Full Text] [Related]
14. CD40 inhibits replication of hepatitis C virus in primary human hepatocytes by c-Jun N terminal kinase activation independent from the interferon pathway.
Rau SJ; Hildt E; Himmelsbach K; Thimme R; Wakita T; Blum HE; Fischer R
Hepatology; 2013 Jan; 57(1):23-36. PubMed ID: 22814930
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.
Zhu H; Dong H; Eksioglu E; Hemming A; Cao M; Crawford JM; Nelson DR; Liu C
Gastroenterology; 2007 Nov; 133(5):1649-59. PubMed ID: 17983809
[TBL] [Abstract][Full Text] [Related]
16. Cell culture and infection system for hepatitis C virus.
Kato T; Date T; Murayama A; Morikawa K; Akazawa D; Wakita T
Nat Protoc; 2006; 1(5):2334-9. PubMed ID: 17406476
[TBL] [Abstract][Full Text] [Related]
17. Understanding hepatitis C viral dynamics with direct-acting antiviral agents due to the interplay between intracellular replication and cellular infection dynamics.
Guedj J; Neumann AU
J Theor Biol; 2010 Dec; 267(3):330-40. PubMed ID: 20831874
[TBL] [Abstract][Full Text] [Related]
18. Development of a robust luciferase reporter 1b/2a hepatitis C virus (HCV) for characterization of early stage HCV life cycle inhibitors.
Chan K; Robinson M; Yang H; Cornew S; Delaney Iv WE
Antiviral Res; 2013 Apr; 98(1):85-92. PubMed ID: 23376631
[TBL] [Abstract][Full Text] [Related]
19. (-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry.
Calland N; Albecka A; Belouzard S; Wychowski C; Duverlie G; Descamps V; Hober D; Dubuisson J; Rouillé Y; Séron K
Hepatology; 2012 Mar; 55(3):720-9. PubMed ID: 22105803
[TBL] [Abstract][Full Text] [Related]
20. Neutralizing antibodies induced by cell culture-derived hepatitis C virus protect against infection in mice.
Akazawa D; Moriyama M; Yokokawa H; Omi N; Watanabe N; Date T; Morikawa K; Aizaki H; Ishii K; Kato T; Mochizuki H; Nakamura N; Wakita T
Gastroenterology; 2013 Aug; 145(2):447-55.e1-4. PubMed ID: 23673355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]